Trials / Completed
CompletedNCT03228680
Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Japanese Women
A Randomised, Controlled, Assessor-blind, Parallel Groups, Multicentre Trial Assessing the Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Japanese Women Undergoing an Assisted Reproductive Technology Programme
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 373 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- Female
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
To demonstrate non-inferiority of FE 999049 compared to FOLLISTIM with respect to number of oocytes retrieved in Japanese IVF/ICSI patients undergoing controlled ovarian stimulation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Follitropin delta | Single daily subcutaneous administration through pre-filled injection pen |
| DRUG | Follitropin beta | Single daily subcutaneous injection in the abdomen |
Timeline
- Start date
- 2017-07-29
- Primary completion
- 2019-06-10
- Completion
- 2019-07-08
- First posted
- 2017-07-25
- Last updated
- 2023-08-24
- Results posted
- 2021-03-24
Locations
17 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT03228680. Inclusion in this directory is not an endorsement.